Responses
Regular and Young Investigator Award Abstracts
Immune-Stimulants and Immune Modulators
1064 Characterization of preclinical anti-tumor and pharmacodynamic activity in response to conditionally active IFNa with or without checkpoint blockade
Compose a Response to This Article
Other responses
No responses have been published for this article.
